JPMorgan Chase & Co. Analysts Give Siemens Healthineers (ETR:SHL) a €54.40 Price Target

Siemens Healthineers (ETR:SHL) has been assigned a €54.40 ($64.00) price objective by research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s price target suggests a potential downside of 0.15% from the stock’s current price.

Several other analysts have also recently commented on SHL. Independent Research set a €51.00 ($60.00) price target on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Tuesday, May 4th. Deutsche Bank Aktiengesellschaft set a €56.00 ($65.88) price target on shares of Siemens Healthineers and gave the stock a “buy” rating in a research note on Tuesday, May 4th. Kepler Capital Markets set a €54.00 ($63.53) price target on shares of Siemens Healthineers and gave the stock a “buy” rating in a research note on Thursday, June 17th. DZ Bank restated a “neutral” rating on shares of Siemens Healthineers in a research report on Friday, June 25th. Finally, Berenberg Bank set a €56.00 ($65.88) target price on shares of Siemens Healthineers and gave the company a “buy” rating in a research report on Thursday, April 29th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of €51.73 ($60.86).

Shares of SHL stock opened at €54.48 ($64.09) on Tuesday. The stock has a market cap of $61.40 billion and a PE ratio of 36.22. Siemens Healthineers has a 52 week low of €35.58 ($41.85) and a 52 week high of €54.52 ($64.14). The company has a debt-to-equity ratio of 98.67, a quick ratio of 2.26 and a current ratio of 2.60. The business has a fifty day moving average of €49.84.

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.

See Also: What is a Secondary Public Offering?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.